Mainz Biomed B.V. (MYNZ) Stock Overview
Explore Mainz Biomed B.V.’s financial performance, market position, analyst ratings, and future outlook.
Mainz Biomed B.V. (MYNZ)
Key Financials
Key Financials
Market Cap
14.7M
P/E Ratio
-1.33
EPS (TTM)
$-5.28
ROE
-10.25%
MYNZ Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Mainz Biomed B.V. (MYNZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 63.84, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.33 and a market capitalization of 14.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.